🇺🇸 FDA
Patent

US 7786149

Thiadiazoles as CXC- and CC- chemokine receptor ligands

granted A61PA61P1/00A61P1/02

Quick answer

US patent 7786149 (Thiadiazoles as CXC- and CC- chemokine receptor ligands) held by Pharmacopeia Drug Discovery, Inc. expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16